Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad K Porter

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Clinical and Vaccine Immunology : CVI|June 27, 2008
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192GJoyce A Lapa, Stephanie A Sincock, Madhumita Ananthakrishnan, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Infection and Immunity|September 24, 2008
Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studiesFrédéric Poly, Timothy D Read, Yu-Han Chen, et al.
Plos Neglected Tropical Diseases|October 3, 2025
Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge modelXueyan Zhang, Jessica Brubaker, Kawsar R Talaat, et al.
Microorganisms|February 24, 2024
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult VolunteersRamiro L Gutiérrez, Chad K Porter, Clayton Harro, et al.
Advances in Nutrition (Bethesda, Md.)|February 23, 2023
Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-AnalysisHeather S Fagnant, Sandra D Isidean, Lydia Wilson, et al.
The Journal of Infectious Diseases|June 2, 2011
Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19Robin McKenzie, Chad K Porter, Joyce A Cantrell, et al.
Nature Communications|December 5, 2022
Impact of international travel and diarrhea on gut microbiome and resistome dynamicsManish Boolchandani, Kevin S Blake, Drake H Tilley, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Diagnostic Microbiology and Infectious Disease|November 12, 2009
The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coliChad K Porter, Mark S Riddle, David R Tribble, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Clinical and Vaccine Immunology : CVI|June 27, 2008
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192GJoyce A Lapa, Stephanie A Sincock, Madhumita Ananthakrishnan, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Infection and Immunity|September 24, 2008
Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studiesFrédéric Poly, Timothy D Read, Yu-Han Chen, et al.
Plos Neglected Tropical Diseases|October 3, 2025
Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge modelXueyan Zhang, Jessica Brubaker, Kawsar R Talaat, et al.
Microorganisms|February 24, 2024
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult VolunteersRamiro L Gutiérrez, Chad K Porter, Clayton Harro, et al.
Advances in Nutrition (Bethesda, Md.)|February 23, 2023
Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-AnalysisHeather S Fagnant, Sandra D Isidean, Lydia Wilson, et al.
The Journal of Infectious Diseases|June 2, 2011
Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19Robin McKenzie, Chad K Porter, Joyce A Cantrell, et al.
Nature Communications|December 5, 2022
Impact of international travel and diarrhea on gut microbiome and resistome dynamicsManish Boolchandani, Kevin S Blake, Drake H Tilley, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Diagnostic Microbiology and Infectious Disease|November 12, 2009
The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coliChad K Porter, Mark S Riddle, David R Tribble, et al.
Pageof 13